Pacira Pharmaceuticals, INC.
Doing business as Pacira Pharmaceuticals INC
At a glance
Employees500+
In business sinceNot reported
HeadquartersParsippany, NJ
US patents56
SAM.gov UEIS29KQL4CCNA9
CAGE code61QS0
Incorporated inCA
- non-opioid therapies
- musculoskeletal pain
- advanced therapies
- gene therapy
- pMVL technology
- EXPAREL
- ZILRETTA
- PCRX-201
- PCRX-2002
Named on the company’s own website, read JUL 29, 2026
CareersCareers page — seen SEP 8, 2026
Supplier designations
For Profit OrganizationManufacturer of Goods
Self-certified by the company in its SAM.gov registration
Patents
56 US patents granted 2012–2025, 34 of them in the five years to SEP 2025.
Pharmaceuticals 44Chemical engineering 12
- Manufacturing of bupivacaine multivesicular liposomesUS 12,370,142 · granted JUL 29, 2025
- Manufacturing of bupivacaine multivesicular liposomesUS 12,318,483 · granted JUN 3, 2025
- Manufacturing of bupivacaine multivesicular liposomesUS 12,296,047 · granted MAY 13, 2025
- Multivesicular liposome formulations of dexamethasoneUS 12,285,435 · granted APR 29, 2025
- Bupivacaine multivesicular liposome formulations and uses thereofUS 12,285,419 · granted APR 29, 2025
Newest 5 shown · Granted to Pacira Pharmaceuticals, Inc. · PatentsView (USPTO), data through SEP 30, 2025 · CC BY 4.0
Their plant
| Facility | City | State | Employees | Status |
|---|---|---|---|---|
| Pacira Pharmaceuticals, INC. | Parsippany | NJ | 500+ | ACTIVE |
Compiled from federal records — EPA, OSHA, SAM.gov and the U.S. Census — and from the company’s own website. Federal source data is public domain. Each plant’s page names the source of every field.